Article FDA Thank You FDA gives companies leeway to go after misinformation, but not free reign
Agency IQ
JULY 12, 2024
In regulation, intended use is defined at 21 CFR 201.128 for drugs and 21 CFR 801.4 for medical devices as “the objective intent of the persons legally responsible for the labeling of” drugs of devices. For drug products, the FDA regulates both product labeling ( 21 CFR 201 ) and promotional labeling ( 21 CFR 202 ).
Let's personalize your content